PO-167 Metabolomics Biomarkers in Breast Cancer Tumours Treated With Neoadjuvant Therapy

doi 10.1136/esmoopen-2018-eacr25.679
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ Publishing Group Ltd

Related search

Neoadjuvant Systemic Therapy in Breast Cancer

2012English

Neoadjuvant Therapy With Cisplatin in BRCA1-positive Breast Cancer Patients

Hereditary Cancer in Clinical Practice
OncologyGenetics
2011English

Pathologic Evaluation of Breast Cancer After Neoadjuvant Therapy

Journal of Pathology and Translational Medicine
Forensic MedicinePathologyHistology
2016English

Response to Neoadjuvant Therapy With Cisplatin in BRCA1-positive Breast Cancer Patients

Breast Cancer Research and Treatment
Cancer ResearchOncology
2008English

Biomarkers and Response to Therapy in Breast Cancer

Clinical Cancer Research
Cancer ResearchOncology
2009English

Neoadjuvant Endocrine Therapy for Estrogen Receptor–Positive Breast Cancer

JAMA Oncology
Cancer ResearchOncology
2016English

Neoadjuvant Endocrine Therapy in Breast Cancer: Current Role and Future Perspectives

ecancermedicalscience
Cancer ResearchOncology
2016English

Is Neoadjuvant Androgen Deprivation Therapy Necessary for Patients With Intermediate-Risk Prostate Cancer Treated With Proton Therapy?

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2016English

Current Treatment of Early Breast Cancer: Adjuvant and Neoadjuvant Therapy

F1000Research
GeneticsMolecular BiologyPharmacologyBiochemistryMicrobiology ImmunologyMedicineToxicologyPharmaceutics
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy